These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25963911)

  • 21. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
    Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
    Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
    Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
    Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
    Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
    J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C; Lemaire C; Luxen A; Plenevaux A
    Nucl Med Biol; 2006 Jul; 33(5):667-75. PubMed ID: 16843842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Imaging of the Programmed Death Ligand 1 by
    González Trotter DE; Meng X; McQuade P; Rubins D; Klimas M; Zeng Z; Connolly BM; Miller PJ; O'Malley SS; Lin SA; Getty KL; Fayadat-Dilman L; Liang L; Wahlberg E; Widmark O; Ekblad C; Frejd FY; Hostetler ED; Evelhoch JL
    J Nucl Med; 2017 Nov; 58(11):1852-1857. PubMed ID: 28588151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET studies of 18F-memantine in healthy volunteers.
    Ametamey SM; Bruehlmeier M; Kneifel S; Kokic M; Honer M; Arigoni M; Buck A; Burger C; Samnick S; Quack G; Schubiger PA
    Nucl Med Biol; 2002 Feb; 29(2):227-31. PubMed ID: 11823128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.
    Kokic M; Honer M; Kessler LJ; Grauert M; Schubiger PA; Ametamey SM
    J Recept Signal Transduct Res; 2002; 22(1-4):123-39. PubMed ID: 12503611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.
    Patel S; Hamill TG; Connolly B; Jagoda E; Li W; Gibson RE
    Nucl Med Biol; 2007 Nov; 34(8):1009-17. PubMed ID: 17998106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo [
    Schoenberger M; Schroeder FA; Placzek MS; Carter RL; Rosen BR; Hooker JM; Sander CY
    ACS Chem Neurosci; 2018 Feb; 9(2):298-305. PubMed ID: 29050469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient radiosynthesis and preclinical evaluation of [
    Singleton TA; Bdair H; Bailey JJ; Choi S; Aliaga A; Rosa-Neto P; Schirrmacher R; Bernard-Gauthier V; Kostikov A
    J Labelled Comp Radiopharm; 2020 Mar; 63(3):144-150. PubMed ID: 31919878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates.
    Shi B; Narayanan TK; Christian BT; Chattopadhyay S; Mukherjee J
    Nucl Med Biol; 2004 Apr; 31(3):303-11. PubMed ID: 15028242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation in rats of [(18)F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors.
    Waterhouse RN; Chang RC; Zhao J; Carambot PE
    Nucl Med Biol; 2006 Feb; 33(2):211-5. PubMed ID: 16546675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([
    Fu H; Tang W; Chen Z; Belov VV; Zhang G; Shao T; Zhang X; Yu Q; Rong J; Deng X; Han W; Myers SJ; Giffenig P; Wang L; Josephson L; Shao Y; Davenport AT; Daunais JB; Papisov M; Yuan H; Li Z; Traynelis SF; Liang SH
    ACS Chem Neurosci; 2019 May; 10(5):2263-2275. PubMed ID: 30698943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
    Fujinaga M; Yamasaki T; Yui J; Hatori A; Xie L; Kawamura K; Asagawa C; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
    J Med Chem; 2012 Mar; 55(5):2342-52. PubMed ID: 22316010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.